BlueLight Therapeutics

BlueLight Therapeutics is a South San Francisco-based biotechnology company that leverages a proprietary, structure-driven platform to develop novel therapeutic molecules against challenging, high-value drug targets. The company uses Second Harmonic Generation (SHG) technology to measure structural changes of biomolecules in real time and at high throughput, enabling discovery of structure-modulating compounds missed by standard activity assays. By coupling knowledge of a drug target's native and disease-relevant biology with this platform, BlueLight can efficiently discover and develop molecules that induce functionally relevant conformational changes in difficult-to-drug targets. The company partners with biopharma organizations to drive discovery and development of novel therapeutics. BlueLight Therapeutics was formerly known as Biodesy Inc., adopting its current name in May 2020. Its investors include 5AM Ventures, Pfizer Ventures, and Alexandria Venture Investments.